Boris Kovatchev

28.3k total citations · 4 hit papers
242 papers, 13.1k citations indexed

About

Boris Kovatchev is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Boris Kovatchev has authored 242 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 195 papers in Endocrinology, Diabetes and Metabolism, 125 papers in Surgery and 120 papers in Genetics. Recurrent topics in Boris Kovatchev's work include Diabetes Management and Research (192 papers), Diabetes and associated disorders (120 papers) and Pancreatic function and diabetes (119 papers). Boris Kovatchev is often cited by papers focused on Diabetes Management and Research (192 papers), Diabetes and associated disorders (120 papers) and Pancreatic function and diabetes (119 papers). Boris Kovatchev collaborates with scholars based in United States, Italy and France. Boris Kovatchev's co-authors include Marc D. Breton, Daniel J. Cox, Claudio Cobelli, William L. Clarke, Linda Gonder‐Frederick, Chiara Dalla Man, Éric Renard, Lalo Magni, Giuseppe De Nicolao and Stacey M. Anderson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Endocrine Reviews.

In The Last Decade

Boris Kovatchev

236 papers receiving 12.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes

2009 591 citations Boris Kovatchev, Marc D. Breton et al. Journal of Diabetes Science and Technology profile →
The UVA/PADOVA Type 1 Diabetes Simulator

2014 554 citations Chiara Dalla Man, Marc D. Breton et al. Journal of Diabetes Science and Technology profile →
Artificial Pancreas: Past, Present, Future

2011 435 citations Claudio Cobelli, Boris Kovatchev et al. Diabetes profile →
One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology

2021 165 citations Marc D. Breton, Boris Kovatchev Diabetes Technology & Therapeutics profile →

Peers

Countries citing papers authored by Boris Kovatchev

Since Specialization

Citations

This map shows the geographic impact of Boris Kovatchev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Kovatchev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Kovatchev more than expected).

Fields of papers citing papers by Boris Kovatchev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Kovatchev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Kovatchev. The network helps show where Boris Kovatchev may publish in the future.

Co-authorship network of co-authors of Boris Kovatchev

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Kovatchev. A scholar is included among the top collaborators of Boris Kovatchev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Kovatchev. Boris Kovatchev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Registration and Real-Life Studies on Automated Insulin Delivery Systems 2025 ·Journal of Diabetes Science and Technology ·Halis Kaan Aktürk, Sue A. Brown, Roy W. Beck, Jennifer L. Sherr, Richard M. Bergenstal, Boris Kovatchev, Robert A. Vigersky, Marc D. Breton, Roman Hovorka, David C. Klonoff, (unknown)	3
2	The Virtual DCCT #3: Relationship of HbA1c and CGM Metrics with Cardiovascular Outcomes 2025 ·Diabetes Technology & Therapeutics ·William B. Horton, Boris Kovatchev, Lauren Kanapka, Roy W. Beck	0
3	The Virtual DCCT: Adding Continuous Glucose Monitoring to a Landmark Clinical Trial for Prediction of Microvascular Complications 2025 ·Diabetes Technology & Therapeutics ·Boris Kovatchev, (unknown), Chiara Fabris, (unknown), Anas El Fathi, Marc D. Breton, Lauren Kanapka, Craig Kollman, Tadej Battelino, Roy W. Beck	8
4	Neural-Net Artificial Pancreas: A Randomized Crossover Trial of a First-in-Class Automated Insulin Delivery Algorithm 2024 ·Diabetes Technology & Therapeutics ·Boris Kovatchev, Alberto Castillo, (unknown), Laura Kollar, Charlotte L. Barnett, Mark D. DeBoer, Sue A. Brown, (unknown)	17
5	Clinically Similar Clusters of Daily Continuous Glucose Monitoring Profiles: Tracking the Progression of Glycemic Control Over Time 2023 ·Diabetes Technology & Therapeutics ·Boris Kovatchev, (unknown)	3
6	Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in Diabetes 2022 ·Diabetes Technology & Therapeutics ·(unknown), Chiara Fabris, Boris Kovatchev	25
7	One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology breakdown → 2021 ·Diabetes Technology & Therapeutics ·Marc D. Breton, Boris Kovatchev	165
8	101-LB: Eighteen-Month Use of Closed-Loop Control (CLC): A Randomized, Controlled Trial 2020 ·Diabetes ·Sue A. Brown, Dan Raghinaru, Bruce A. Buckingham, Yogish C. Kudva, Lori M. Laffel, Carol J. Levy, Jordan E. Pinsker, R. Paul Wadwa, John W. Lum, Craig Kollman, Roy W. Beck, Boris Kovatchev	1
9	Closed loop control in adolescents and children during winter sports: Use of the Tandem Control‐IQ AP system 2019 ·Pediatric Diabetes ·Laya Ekhlaspour, Gregory P. Forlenza, Daniel R. Cherñavvsky, David M. Maahs, R. Paul Wadwa, Mark D. DeBoer, Laurel H. Messer, Marissa Town, (unknown), (unknown), Boris Kovatchev, Bruce A. Buckingham, Marc D. Breton	52
10	Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia 2019 ·Diabetes Technology & Therapeutics ·Stacey M. Anderson, Bruce A. Buckingham, Marc D. Breton, J. Robic, Charlotte L. Barnett, Christian Wakeman, Mary C. Oliveri, Sue A. Brown, Trang T. Ly, Paula Clinton, Liana Hsu, Ryan Kingman, Lisa Norlander, (unknown), (unknown), Boris Kovatchev	46
11	Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors 2018 ·Diabetes Care ·David C. Klonoff, Joan Lee Parkes, Boris Kovatchev, David Kerr, Wendy C. Bevier, Ronald Brazg, Mark P. Christiansen, Timothy S. Bailey, James H. Nichols, Michael A. Kohn	101
12	Multinight “Bedside” Closed-Loop Control for Patients with Type 1 Diabetes 2015 ·Diabetes Technology & Therapeutics ·Sue A. Brown, Boris Kovatchev, Marc D. Breton, Stacey M. Anderson, Patrick Keith-Hynes, Stephen D. Patek, Boyi Jiang, (unknown), (unknown), Daniela Bruttomesso, Angelo Avogaro, Simone Del Favero, Federico Boscari, Silvia Galasso, R. Visentin, (unknown), Claudio Cobelli	39
13	The University of Virginia/Padova Type 1 Diabetes Simulator Matches the Glucose Traces of a Clinical Trial 2014 ·Diabetes Technology & Therapeutics ·R. Visentin, Chiara Dalla Man, Boris Kovatchev, Claudio Cobelli	74
14	Remote Glucose Monitoring in Camp Setting Reduces the Risk of Prolonged Nocturnal Hypoglycemia 2013 ·Diabetes Technology & Therapeutics ·Daniel J. DeSalvo, Patrick Keith-Hynes, Thomas A. Peyser, J. Place, (unknown), Darrell M. Wilson, Breanne Harris, Paula Clinton, Boris Kovatchev, Bruce A. Buckingham	56
15	Accuracy and Robustness of Dynamical Tracking of Average Glycemia (A1c) to Provide Real-Time Estimation of Hemoglobin A1c Using Routine Self-Monitored Blood Glucose Data 2013 ·Diabetes Technology & Therapeutics ·Boris Kovatchev, Frank Flacke, Jochen Sieber, Marc D. Breton	21
16	Reduced Daily Risk of Glycemic Variability: Comparison of Exenatide with Insulin Glargine 2009 ·Diabetes Technology & Therapeutics ·Anthony L. McCall, Daniel J. Cox, Robert G. Brodows, John Crean, Don Johns, Boris Kovatchev	37
17	A Novel Analytical Method for Assessing Glucose Variability: Using CGMS in Type 1 Diabetes Mellitus 2006 ·Diabetes Technology & Therapeutics ·Anthony L. McCall, Daniel J. Cox, John Crean, (unknown), Boris Kovatchev	57
18	Numerical Estimation of HbA1c from Routine Self-Monitoring Data in People with Type 1 and Type 2 Diabetes Mellitus 2004 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Boris Kovatchev, Daniel J. Cox	2
19	Treatment of Childhood Encopresis: A Randomized Trial Comparing Three Treatment Protocols 2002 ·Journal of Pediatric Gastroenterology and Nutrition ·Stephen M. Borowitz, Daniel J. Cox, James L. Sutphen, Boris Kovatchev	6
20	Dynamic network model of glucose counterregulation in subjects with insulin-requiring diabetes 2000 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Boris Kovatchev, Martin Straume, Leon S. Farhy, Daniel J. Cox	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact